Skip to main content

Advertisement

Log in

PET assessment of disease activity in children with juvenile idiopathic arthritis

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background

The degree of 18-fluorodeoxyglucose (FDG) uptake is previously reported to correlate with physical examination and laboratory tests for evaluating disease activity in patients with rheumatoid arthritis. The clinical validity of 18F-FDG positron emission tomography (PET) has not been evaluated in juvenile idiopathic arthritis (JIA).

Objective

To assess the relationship between 18F-FDG PET uptake and disease activity in children with JIA.

Materials and methods

A total of 560 joints in 28 children (mean age, 5.4 years; range, 1–16 years) with JIA who had undergone whole-body 18F-FDG PET before treatment were retrospectively assessed clinically, biochemically and radiographically. PET images were assessed independently by two readers. We investigated the relationships between the degree of synovial 18F-FDG uptake and radiographic and clinical symptoms and laboratory findings.

Results

Joint tenderness and swelling had a positive association with abnormal 18F-FDG uptake in the joint [odds ratio (OR) 5.37, 7.12, respectively]. The standardized uptake value (SUV) max correlated with the neutrophil count, plasma C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and matrix metalloproteinase (MMP) 3. Joint erosion (OR, 6.17), soft-tissue swelling (OR, 3.77), major joints involvement (OR, 3.50), tenderness (OR, 5.22), and CRP concentration in plasma (OR, 1.81) were positively associated with SUVmax.

Conclusion

The degree of 18F-FDG uptake may be associated with the severity of synovitis in children with JIA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778

    Article  CAS  PubMed  Google Scholar 

  2. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392

    PubMed  Google Scholar 

  3. Lovell DJ, Giannini EH, Reiff A et al (2000) Etarercept in children with polyarticular rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763–769

    Article  CAS  PubMed  Google Scholar 

  4. Russo RA, Katsicas MM, Zalazko M (2002) Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 20:723–726

    CAS  PubMed  Google Scholar 

  5. Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093–1101

    Article  CAS  PubMed  Google Scholar 

  6. Gerloni V, Pontikaki I, Gattinara M et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 52:548–553

    Article  CAS  PubMed  Google Scholar 

  7. Katsicas MM, Russo RA (2005) Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 23:545–548

    CAS  PubMed  Google Scholar 

  8. Yokota S, Imagawa T, Miyamae T et al (2004) Long-term therapeutic experience of humanized anti-IL-6 receptor monoclonal antibody (aIL-6R Mab) in systemic-onset juvenile idiopathic arthritis (So-JIA). Arthritis Rheum 50:S438

    Google Scholar 

  9. Yokota S, Miyamae T, Imagawa T et al (2005) Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. Clin Rev Allergy Immunol 28:231–238

    Article  CAS  PubMed  Google Scholar 

  10. Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase II trial. Lancet 371:998–1006

    Article  CAS  PubMed  Google Scholar 

  11. Reed MH, Wilmot DM (1991) The radiology of juvenile rheumatoid arthritis. A review of the English language literature. J Rheumatol Suppl 31:2–22

    CAS  PubMed  Google Scholar 

  12. Rossi F, Di Dia F, Galipo O et al (2006) Use of Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 55:717–723

    Article  PubMed  Google Scholar 

  13. Doria AS, Babyn P, Feldman B (2006) A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis. Pediatr Radiol 36:759–772

    Article  PubMed  Google Scholar 

  14. Malattia C, Damasio MB, Magnaguagno F et al (2008) Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum 59:1764–1772

    Article  PubMed  Google Scholar 

  15. Pedersen TK, Kuseler A, Gelineck J et al (2008) A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol 35:1668–1675

    PubMed  Google Scholar 

  16. Wipke BT, Wang Z, Kim J et al (2002) Dynamic visualization of joint specific autoimmune response through positron emission tomography. Nat Immunol 3:366–372

    Article  CAS  PubMed  Google Scholar 

  17. Fonseca A, Wagner J, Yamaga LI et al (2008) (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis. J Clin Rheumatol 14:307

    Article  PubMed  Google Scholar 

  18. Beckers C, Ribbens C, André B et al (2004) Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45:956–964

    CAS  PubMed  Google Scholar 

  19. Giannini EH, Ruperto N, Ravelli A et al (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202–1209

    CAS  PubMed  Google Scholar 

  20. Polisson RP, Schoenberg OI, Fischman A et al (1995) Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38:819–825

    Article  CAS  PubMed  Google Scholar 

  21. Goerres GW, Forster A, Uebelhart D et al (2006) F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 31:386–390

    Article  PubMed  Google Scholar 

  22. Elzinga EH, van der Laken CJ, Comans EF et al (2007) 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 9:357–360

    Article  CAS  PubMed  Google Scholar 

  23. Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33:275–280

    Article  PubMed  Google Scholar 

  24. Ju JH, Kang KY, Kim IJ et al (2008) Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images. Clin Rheumatol 27:S39–S41

    Article  PubMed  Google Scholar 

  25. Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48:3077–3084

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Jin Lee, Hiroaki Hagiwara, Zenjiro Sekikawa, Keisuke Yoshida, Tomohiro Yoneyama, as well as Masashi Kawaguchi, the research staff of the study for their help with data collection. Gratitude is expressed to Akiko Suzuki, Ryogo Minamimoto and Hirofumi Shibata for their assistance with data analyses.

This work was supported in part by grants from Scientific Research Expenses for Health and Welfare Programs and the Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ukihide Tateishi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tateishi, U., Imagawa, T., Kanezawa, N. et al. PET assessment of disease activity in children with juvenile idiopathic arthritis. Pediatr Radiol 40, 1781–1788 (2010). https://doi.org/10.1007/s00247-010-1716-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-010-1716-5

Keywords

Navigation